<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2763556/" ref="ordinalpos=4986&amp;ncbi_uid=2431738&amp;link_uid=PMC2763556" image-link="/pmc/articles/PMC2763556/figure/F3/" class="imagepopup">Figure 3. In vivo effects of alterations in the Fas Ag <span class="highlight" style="background-color:">signaling</span> <span class="highlight" style="background-color:">pathway</span>.  From: Human and mouse colon cancer utilizes CD95 <span class="highlight" style="background-color:">signaling</span> for local growth and metastatic spread to liver. </a></div><br /><div class="p4l_captionBody">A) MC38 or M38/FLIP/L cells were injected subcutaneously or intravenously in C57BL/6 mice. At 4 weeks local and metastatic tumor growth was evaluated. B) Tumor characteristics.N=10 for all groups except MC38 where n=30, MC38/FLIP where n=9. All tumors were evaluated at 4 weeks except * = 3 weeks due to large tumor size).</div></div>